Launch week offerEnds in00h00m00s

Renato Seracchioli

Has grant

Professore Ordinario

University of Bologna
Country flagItaly

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

‘Mona Lisa smile’: professional education and early diagnosis of endometriosis in adolescence.

Open Date: 2022-12-01

Close Date:

Articles (12)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Objective To assess the prevalence of adenomyosis at pathologic examination, and its association with obstetric complications, peripartum maternal clinical characteristics and neonatal birth weight in patients undergoing postpartum hysterectomy due to postpartum hemorrhage (PPH). Methods A multicenter, observational, retrospective, cohort study was carried out including all women who underwent postpartum hysterectomy due to PPH at gestational week 23+0 or later, between January 2010 and May 2023. Patients were categorized into two groups based on the presence of adenomyosis at pathologic examination, and were compared for obstetric complications, peripartum maternal clinical characteristics, and neonatal birth weight. Results The histologically‐based prevalence of adenomyosis in patients undergoing postpartum hysterectomy due to PPH was 39.4%. Adenomyosis was associated with a longer hospitalization time (regression coefficient: 4.43 days, 95% CI: 0.34–8.52, P = 0.034) and a higher risk of hypertensive disorders (OR: 5.82, 95% CI: 1.38–24.46, P = 0.016), threatened preterm labor (OR: 3.34, 95% CI: 1.08–10.31, P = 0.036), urgent/emergency C‐section (OR: 24.15, 95% CI: 2.60–223.96, P = 0.005), postpartum maternal complications (OR: 4.96, 95% CI: 1.48–16.67, P = 0.012), maternal intensive care unit admission (OR: 3.56, 95% CI: 1.05–12.05, P = 0.041), and low birth weight neonates (OR: 3.8, 95% CI: 1.32–11.02, P = 0.013). Conclusion In patients undergoing postpartum hysterectomy due to PPH, adenomyosis is a highly prevalent condition among, and is associated with adverse obstetric, maternal, and neonatal outcomes.

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (11)

Antonio Raffone

M. D

Università degli Studi di Napoli Federico II

ITALY
View details

Virginia Vargiu

Università Cattolica del Sacro Cuore -Fondazione Policlinico Universitario Agostino Gemelli - IRCCS

ITALY
View details

Federico Andrea Galatolo

Assistant Professor

University of Pisa

ITALY
View details

Paolo Casadio

Dipartimento di Medicina e Chirurgia, Università degli Studi di Milano-Bicocca

ITALY
View details

Gianluca Gennarelli

Azienda Ospedaliero Universitaria Città della Salute e della Scienza di Torino

ITALY
View details

GIAMPIERO CAPOBIANCO

Director Complex Unit of Ostetrics and Gynecology. FULL Professor of Gynecology and Obstetrics, Sassari University, Italy

-

ITALY
View details

Antonio Mollo

Docenti di ruolo di IIa fascia

University of Salerno

ITALY
View details

JACOPO LENZI

Associate Professor

University of Bologna

ITALY
View details

Francesco Fedele

Medical Residency in Obstetrics and Gynaecology

Ospedale San Raffaele

ITALY
View details

Nicolò Brandi

IRCCS Azienda Ospedaliero-Universitaria di Bologna

ITALY
View details

Lucia Lazzeri

Docenti di ruolo di IIa fascia

University of Siena

ITALY
View details